Gamida Cell - Cord Blood Transplant

Latest News

Enhancing the Power of Stem Cell Therapy

Gamida Cell Ltd. is a leader in cell therapy technologies and products for transplantation and adaptive immune therapy. The company’s pipeline of products are in development with a potential to treat a wide range of conditions including: blood cancers, non-malignant hematological diseases such as sickle cell disease and thalassemia, neutropenia and acute radiation syndrome, autoimmune diseases, solid tumors and genetic metabolic diseases as well as conditions that can be helped by adaptive immune therapy such as solid and blood cancers refractory to chemotherapy. Gamida Cell’s therapeutic candidates contain populations of therapeutic stem cells, selected from non-controversial sources such as umbilical cord blood, bone marrow and peripheral blood, which are expanded in culture.

The company is currently focused on clinically developing NiCord® as an alternative treatment for blood cancers.
Read More.

Pipeline Products

To learn more about our products and clinical trials, please fill in:
* Message:
* Please type in the verification code as appears on the image: